🔗 Visit the ClinicalTrials.gov page for NCT02383212
| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | A Mini-Review for Cancer Immunotherapy: Molecular Understanding of PD-1/PD-L1 Pathway & Translational Blockade of Immune Checkpoints. | Int J Mol Sci | 2016 | 0.97 |
| 2 | Trial Watch: Immunotherapy plus radiation therapy for oncological indications. | Oncoimmunology | 2016 | 0.81 |
| 3 | Current clinical trials testing the combination of immunotherapy with radiotherapy. | J Immunother Cancer | 2016 | 0.81 |
| 4 | Immune Checkpoint Modulation in Colorectal Cancer: What's New and What to Expect. | J Immunol Res | 2015 | 0.78 |
| 5 | Responses of metastatic basal cell and cutaneous squamous cell carcinomas to anti-PD1 monoclonal antibody REGN2810. | J Immunother Cancer | 2016 | 0.77 |
| 6 | Single dose denileukin diftitox does not enhance vaccine-induced T cell responses or effectively deplete Tregs in advanced melanoma: immune monitoring and clinical results of a randomized phase II trial. | J Immunother Cancer | 2016 | 0.75 |